Edition:
India

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

90.74EUR
2:40pm IST
Change (% chg)

€0.78 (+0.87%)
Prev Close
€89.96
Open
€90.50
Day's High
€90.84
Day's Low
€90.30
Volume
64,248
Avg. Vol
561,323
52-wk High
€115.20
52-wk Low
€87.23

Select another date:

Thu, Jan 11 2018

BRIEF-Forty Seven Says Agreement With Merck KGAA To Conduct Clinical Trials For Patients With Ovarian Cancer

* FORTY SEVEN - AGREEMENT WITH MERCK KGAA TO CONDUCT PHASE 1B CLINICAL TRIAL COMBINING HU5F9-G4 WITH AVELUMAB IN PATIENTS WITH OVARIAN CANCER Source text for Eikon: Further company coverage:

Nestle frontrunner for Merck KGaA's consumer health business: Bloomberg

ZURICH Nestle is the frontrunner to buy Merck KGaA's consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with the matter.

Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg

ZURICH, Jan 10 Nestle is the frontrunner to buy Merck KGaA's consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with the matter.

BRIEF-Juniper Pharmaceuticals Announces ‍Extension Of Supply Agreement For Crinone

* JUNIPER PHARMACEUTICALS ANNOUNCES 4.5-YEAR EXTENSION THROUGH 2024 OF CRINONE® SUPPLY AGREEMENT WITH MERCK KGAA, DARMSTADT, GERMANY

BRIEF-HTG Molecular Diagnostics Expands Its Collaboration With Merck

* HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY

BRIEF-Merck And Bluebird Bio Sign Supply Agreement For Commercial Production Of Viral Vectors

* MERCK AND BLUEBIRD BIO SIGN SUPPLY AGREEMENT FOR COMMERCIAL PRODUCTION OF VIRAL VECTORS Source text - http://bit.ly/2DfAvDy Further company coverage: (Gdynia Newsroom)

Germany's Merck in fresh bid to enter U.S. MS pill market

FRANKFURT Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated its ambitions almost seven years ago.

UPDATE 2-Germany's Merck in fresh bid to enter U.S. MS pill market

* Unit head Garijo says targeting most severely affected patients

Perrigo lines up bid for Merck's consumer health unit: sources

LONDON/FRANKFURT Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

UPDATE 1-Perrigo lines up bid for Merck's consumer health unit -sources

* Perrigo to submit non-binding offer for Merck KGaA's OTC unit

Select another date: